The value of genetic polymorphisms to predict toxicity in metastatic colorectal patients with irinotecan-based regimens

Purpose We are trying to identify predictive factors of high risk of toxicity by analyzing candidate genes in the irinotecan pathways in order to identify useful tools to improve mCRC patient management under real practice conditions.